ArticleBiotechnology letters2025
A precisely regulated Streptomyces expression system pTZYp facilitated by the strong promoter stnY and cmt operon.
Article in Biotechnology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
One of the characteristics of actinomycetes, especially streptomycetes, is the high GC content in their genome, which often leads to the failure of heterologous expression in E. coli, and thus hinders in vitro enzyme activity experiments. Therefore, we have developed a precisely regulated and efficient Streptomyces expression system, pTZYp, that relied on the strong promoter stnY and the cmt operon. As tested in three model Streptomyces strains (S. albus J1074, S. coelicolor M1152 and S. lividans TK24), the reporter protein sfGFP was not detected without the addition of the inducer cumate, whereas sfGFP was significantly produced when a certain amount of inducer cumate was added to the medium, demonstrating that the pTZYp expression system can achieve the goal of precise regulation and efficient expression. After optimization of the expression conditions, the maximum sfGFP production was obtained when the inducer was added to the final concentration of 100 μM and cultivated for about 24 h. pTZYp has also been used to express other six non-model proteins in Streptomyces, and all of them have been successfully expressed. The pTZYp expression system demonstrated robustness, high efficiency (relying on the stnY promotor), precise regulation (relying on cmt operon and moderate production of regulatory protein CymR) and low experimental cost (relying on the lower cost of the inducer cumate), which may be an efficient and widely applicable heterologous expression tool for genes with high GC content in actinomycetes.
Indexed as
Identifiers
40794218What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.